Third consecutive win recognizes BPGbio’s NAi® platform for advancing AI-developed drugs into clinical success Biotech ...

Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies by applying its proprietary technologies to its Tumor ...

Interventions targeting drinking water safety and responsible dog management could reduce echinococcosis incidence in China.

Vasta Platform Limited ? "Vasta" or the "Company" announces today its financial and operating results for the third quarter of 2025 (3Q25) ended September 30, 2025. Financial results are expressed in ...

Medicare Advantage plans that place greater restrictions on home health agency care delivery may have more adverse patient outcomes than plans that provide episodic payments.